JARVIS EYECARE LIMITED
- · Thesis: well-run, low negotiation leverage
No material changes in the last 30 days.
No snapshot from 90 days ago — start tracking from today.
No snapshot from 180 days ago — start tracking from today.
Opportunity 78/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (73/100).
Data confidence
Overall: medium (76/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2025-01-31 | 2024-01-31 |
|---|---|---|
| Average employees | 1100 | 900 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Corporate timeline (19 events)Click to expand
- 2025-10-27📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-10-07📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-10-23📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-02-06📄change-person-director-company-with-change-dateofficers · CH01
- 2023-02-06📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2023-02-06📄change-person-secretary-company-with-change-dateofficers · CH03
- 2022-10-05📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-10-25📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-09-08📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-10-02📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2018-10-17📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2017-10-10📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2016-10-27📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2016-03-23📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2015-10-13📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2013-01-25🏢Company incorporatedAs JARVIS EYECARE LIMITED
- 2013-01-25➕JARVIS, Susan Bryony appointedsecretary
- 2013-01-25➕JARVIS, Ian Ogilvy appointeddirector
- 2013-01-25➕JARVIS, Susan Bryony appointeddirector
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
- +Founder name in company name: Company name contains director surname "JARVIS" — strong identity link between founder and business.
- +Senior director age: Director aged approximately 64 — approaching natural succession window.
- +Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.
Succession & seller-readiness
Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.
- primaryFounder aged 63+: Senior director is approximately 64. Approaching typical UK retirement age — succession thinking likely.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
- secondary12+ year tenure: Director in role 13 years.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Ian Ogilvy Jarvis Individual · British · DOB 02/1962 · age 64 | 25–50% | — | 25-50% shares | 06/04/2016 |
Mrs Susan Bryony Jarvis Individual · British · DOB 02/1964 · age 62 | 25–50% | — | 25-50% shares | 06/04/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · DD postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| POSITIVE STEPS INITIATIVES LIMITED→ SC272286 · est 2004 | £300.5k £216.4k–£384.7k | — | — | 2 | 21y | 83 | 75y |
| BALFIELD PROPERTIES LTD→ SC334044 · est 2007 | — | — | — | 1400 | 18y | 83 | 66y |
| THE BRAE RIDING FOR THE DISABLED→ SC205733 · est 2000 | — | — | — | 7 | 26y | 83 | 83y |
| CAALCARE CARE AND SUPPORT SERVICES LIMITED→ SC300007 · est 2006 | — | — | — | 1300 | 20y | 82 | 69y |
| F.M.S.E. MACFARLANE LIMITED→ SC253335 · est 2003 | — | — | — | 9 | 22y | 82 | 80y |
| ST. DAVID'S CARE (FORFAR) LIMITED→ SC304274 · est 2006 | — | — | £734.8k | — | 20y | 82 | 65y |
| CARNOUSTIE, BARRY & PANBRIDE SICK NURSING ASSOCIATION→ SC169926 · est 1996 · no financials extracted | — | — | — | — | 29y | 81 | 77y |
| DEAF LINKS→ SC353562 · est 2009 | — | — | — | 1400 | 17y | 81 | 85y |
| FORFAR DAY CARE CENTRE→ SC239605 · est 2002 | — | — | — | 1000 | 23y | 81 | 86y |
| ICDAS FOUNDATION→ SC305836 · est 2006 · no financials extracted | — | — | — | — | 19y | 81 | 77y |
| TAYSIDE HEALTHCARE ARTS TRUST→ SC307393 · est 2006 | — | — | — | 100 | 19y | 81 | 85y |
| ADASTRA MEDICAL STAFF SOLUTIONS LIMITED→ SC315882 · est 2007 | — | — | £253.1k | — | 19y | 80 | 71y |
6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (3 active · 0 resigned)
Click a director name to see their full track record across all companies.